SalioGen Therapeutics Strengthens its Leadership Team to Advance its Gene Coding™ Platform
SalioGen Therapeutics Strengthens its Leadership Team to Advance its Gene Coding™ Platform CAMBRIDGE, Mass. – July 20, 2022 – SalioGen Therapeutics, a privately held biotechnology company developing Gene CodingTM, a new category of genetic medicine, today announced the expansion of its leadership team with the addition of five highly accomplished scientists, physicians and biotech industry …